T1	NC 0 5	Mujer
#1	Norm T1	mujer NCFS000
T2	SP 6 8	de
#2	Norm T2	de SPS00
T3	Z 9 11	58
#3	Norm T3	58 Z
T4	NC 12 16	años
#4	Norm T4	año NCMP000
T5	VM 17 30	diagnosticada
#5	Norm T5	diagnosticar VMP00SF
T6	SP 31 33	de
#6	Norm T6	de SPS00
T7	NC 34 42	artritis
#7	Norm T7	artritis NCFN000
T8	AQ 43 53	reumatoide
#8	Norm T8	reumatoide AQ0CS0
T9	Fpa 54 55	(
#9	Norm T9	( Fpa
T10	NC 55 57	AR
#10	Norm T10	AR NC00000
T11	Fpt 57 58	)
#11	Norm T11	) Fpt
T12	AQ 59 71	seropositiva
#12	Norm T12	seropositivo AQ0FS0
T13	Fc 71 72	,
#13	Norm T13	, Fc
T14	AQ 73 80	erosiva
#14	Norm T14	erosivo AQ0FS0
T15	CC 81 82	y
#15	Norm T15	y CC
T16	AQ 83 90	nodular
#16	Norm T16	nodular AQ0CS0
T17	SP 91 94	con
#17	Norm T17	con SPS00
T18	NC 95 102	títulos
#18	Norm T18	título NCMP000
T19	AQ 103 108	altos
#19	Norm T19	alto AQ0MP0
T20	SP 109 111	de
#20	Norm T20	de SPS00
T21	NC 112 118	factor
#21	Norm T21	factor NCMS000
T22	AQ 119 129	reumatoide
#22	Norm T22	reumatoide AQ0CS0
T23	SP 130 132	de
#23	Norm T23	de SPS00
T24	Z 133 135	15
#24	Norm T24	15 Z
T25	NC 136 140	años
#25	Norm T25	año NCMP000
T26	SP 141 143	de
#26	Norm T26	de SPS00
T27	NC 144 153	evolución
#27	Norm T27	evolución NCFS000
T28	Fp 153 154	.
#28	Norm T28	. Fp
T29	VA 155 160	Había
#29	Norm T29	haber VAII1S0
T30	VM 161 169	recibido
#30	Norm T30	recibir VMP00SM
T31	NC 170 181	tratamiento
#31	Norm T31	tratamiento NCMS000
T32	AQ 182 188	previo
#32	Norm T32	previo AQ0MS0
T33	SP 189 192	con
#33	Norm T33	con SPS00
T34	AQ 193 203	diferentes
#34	Norm T34	diferente AQ0CP0
T35	NC 204 212	fármacos
#35	Norm T35	fármaco NCMP000
T36	AQ 213 226	modificadores
#36	Norm T36	modificador AQ0MP0
T37	SP 227 229	de
#37	Norm T37	de SPS00
T38	DA 230 232	la
#38	Norm T38	el DA0FS0
T39	NC 233 243	enfermedad
#39	Norm T39	enfermedad NCFS000
T40	Fpa 244 245	(
#40	Norm T40	( Fpa
T41	NC 245 249	FAME
#41	Norm T41	FAME NC00000
T42	Fpt 249 250	)
#42	Norm T42	) Fpt
T43	Fd 250 251	:
#43	Norm T43	: Fd
T44	NC 252 269	hidroxicloroquina
#44	Norm T44	hidroxicloroquina NCFS000
T45	Fc 269 270	,
#45	Norm T45	, Fc
T46	NC 271 284	sulfasalacina
#46	Norm T46	sulfasalacina NCFS000
T47	Fc 284 285	,
#47	Norm T47	, Fc
T48	NC 286 298	ciclosporina
#48	Norm T48	ciclosporina NCFS000
T49	CC 299 300	y
#49	Norm T49	y CC
T50	NC 301 312	leflunomida
#50	Norm T50	leflunomida NC00000
T51	Fc 312 313	,
#51	Norm T51	, Fc
T52	VM 314 323	retirados
#52	Norm T52	retirar VMP00PM
T53	SP 324 327	por
#53	Norm T53	por SPS00
T54	NC 328 338	ineficacia
#54	Norm T54	ineficacia NCFS000
T55	Fp 338 339	.
#55	Norm T55	. Fp
T56	VM 340 346	Seguía
#56	Norm T56	seguir VMII3S0
T57	NC 347 358	tratamiento
#57	Norm T57	tratamiento NCMS000
T58	SP 359 361	de
#58	Norm T58	de SPS00
T59	NC 362 367	fondo
#59	Norm T59	fondo NCMS000
T60	SP 368 371	con
#60	Norm T60	con SPS00
T61	NC 372 383	metrotexato
#61	Norm T61	metotrexato NCMS000
T62	Z 384 386	25
#62	Norm T62	25 Z
T63	NC 386 388	mg
#63	Norm T63	mg NC00000
T64	Fh 388 389	/
#64	Norm T64	/ Fh
T65	AQ 389 398	semanales
#65	Norm T65	semanal AQ0CP0
T66	Fh 398 399	/
#66	Norm T66	/ Fh
T67	NC 399 401	sc
#67	Norm T67	sc NC00000
T68	Fc 401 402	,
#68	Norm T68	, Fc
T69	NC 403 413	prednisona
#69	Norm T69	prednisona NCFS000
T70	Z 414 418	5-10
#70	Norm T70	5-10 Z
T71	NC 418 420	mg
#71	Norm T71	mg NC00000
T72	Fh 420 421	/
#72	Norm T72	/ Fh
T73	NC 421 424	día
#73	Norm T73	día NCMS000
T74	AQ 425 434	variables
#74	Norm T74	variable AQ0CP0
T75	CC 435 436	e
#75	Norm T75	y CC
T76	NC 437 447	infliximab
#76	Norm T76	infliximab NC00000
T77	Z 448 449	5
#77	Norm T77	5 Z
T78	NC 449 451	mg
#78	Norm T78	mg NC00000
T79	Fh 451 452	/
#79	Norm T79	/ Fh
T80	NC 452 454	kg
#80	Norm T80	kg NC00000
T81	Fh 454 455	/
#81	Norm T81	/ Fh
T82	Z 455 457	IV
#82	Norm T82	IV Z
T83	Fh 457 458	/
#83	Norm T83	/ Fh
T84	Z 458 459	8
#84	Norm T84	8 Z
T85	NC 460 467	semanas
#85	Norm T85	semana NCFP000
T86	SP 468 471	con
#86	Norm T86	con SPS00
T87	DI 472 474	un
#87	Norm T87	uno DI0MS0
T88	NC 475 482	control
#88	Norm T88	control NCMS000
T89	AQ 483 492	aceptable
#89	Norm T89	aceptable AQ0CS0
T90	SP 493 495	de
#90	Norm T90	de SPS00
T91	DA 496 498	la
#91	Norm T91	el DA0FS0
T92	NC 499 509	enfermedad
#92	Norm T92	enfermedad NCFS000
T93	SP 510 512	en
#93	Norm T93	en SPS00
T94	DA 513 516	los
#94	Norm T94	el DA0MP0
T95	AO 517 524	últimos
#95	Norm T95	último AO0MP0
T96	Z 525 526	2
#96	Norm T96	2 Z
T97	NC 527 531	años
#97	Norm T97	año NCMP000
T98	SP 532 535	con
#98	Norm T98	con SPS00
T99	AQ 536 540	baja
#99	Norm T99	bajo AQ0FS0
T100	NC 541 550	actividad
#100	Norm T100	actividad NCFS000
T101	SP 551 554	sin
#101	Norm T101	sin SPS00
T102	VM 555 563	alcanzar
#102	Norm T102	alcanzar VMN0000
T103	DA 564 566	la
#103	Norm T103	el DA0FS0
T104	NC 567 575	remisión
#104	Norm T104	remisión NCFS000
T105	AQ 576 584	completa
#105	Norm T105	completo AQ0FS0
T106	Fp 584 585	.
#106	Norm T106	. Fp
T107	SP 586 588	En
#107	Norm T107	en SPS00
T108	DP 589 591	su
#108	Norm T108	su DP3CS0
T109	NC 592 601	evolución
#109	Norm T109	evolución NCFS000
T110	VM 602 610	presentó
#110	Norm T110	presentar VMIS3S0
T111	DI 611 614	una
#111	Norm T111	uno DI0FS0
T112	NC 615 623	artritis
#112	Norm T112	artritis NCFN000
T113	AQ 624 631	séptica
#113	Norm T113	séptico AQ0FS0
T114	SP 632 634	de
#114	Norm T114	de SPS00
T115	NC 635 642	tobillo
#115	Norm T115	tobillo NCMS000
T116	NC 643 650	derecho
#116	Norm T116	derecho NCMS000
T117	SP 651 654	con
#117	Norm T117	con SPS00
T118	NC 655 662	cultivo
#118	Norm T118	cultivo NCMS000
T119	SP 663 665	de
#119	Norm T119	de SPS00
T120	NC 666 673	líquido
#120	Norm T120	líquido NCMS000
T121	AQ 674 682	sinovial
#121	Norm T121	sinovial AQ0CS0
T122	NC 683 691	positivo
#122	Norm T122	positivo NCMS000
T123	SP 692 696	para
#123	Norm T123	para SPS00
T124	NP 697 711	Staphylococcus
#124	Norm T124	staphylococcus NP00000
T125	NC 712 718	aureus
#125	Norm T125	aureus NC00000
T126	Fp 718 719	.
#126	Norm T126	. Fp
T127	P0 720 722	Se
#127	Norm T127	se P00CN000
T128	VM 723 729	retiró
#128	Norm T128	retirar VMIS3S0
T129	NC 730 740	infliximab
#129	Norm T129	infliximab NC00000
T130	CC 741 742	y
#130	Norm T130	y CC
T131	P0 743 745	se
#131	Norm T131	se P00CN000
T132	VM 746 752	inició
#132	Norm T132	iniciar VMIS3S0
T133	NC 753 764	tratamiento
#133	Norm T133	tratamiento NCMS000
T134	SP 765 768	con
#134	Norm T134	con SPS00
T135	NC 769 783	antibioterapia
#135	Norm T135	antibioterapia NCFS000
T136	AQ 784 795	intravenosa
#136	Norm T136	intravenoso AQ0FS0
T137	Fp 795 796	.
#137	Norm T137	. Fp
T138	SP 797 798	A
#138	Norm T138	A SPS00
T139	DA 799 802	los
#139	Norm T139	el DA0MP0
T140	Z 803 804	3
#140	Norm T140	3 Z
T141	NC 805 810	meses
#141	Norm T141	mes NCMP000
T142	VM 811 819	consulta
#142	Norm T142	consultar VMIP3S0
T143	SP 820 823	por
#143	Norm T143	por SPS00
T144	NC 824 827	ojo
#144	Norm T144	ojo NCMS000
T145	AQ 828 832	rojo
#145	Norm T145	rojo AQ0MS0
T146	Fc 832 833	,
#146	Norm T146	, Fc
T147	NC 834 839	dolor
#147	Norm T147	dolor NCMS000
T148	AQ 840 847	intenso
#148	Norm T148	intenso AQ0MS0
T149	AQ 848 861	periorbitario
#149	Norm T149	periorbitario AQ0MS0
T150	CC 862 863	y
#150	Norm T150	y CC
T151	NC 864 873	fotofobia
#151	Norm T151	fotofobia NCFS000
T152	Fp 873 874	.
#152	Norm T152	. Fp
T153	VM 875 883	Presenta
#153	Norm T153	presentar VMIP3S0
T154	VM 884 894	infiltrado
#154	Norm T154	infiltrar VMP00SM
T155	AQ 895 902	corneal
#155	Norm T155	corneal AQ0CS0
T156	NC 903 913	periférico
#156	Norm T156	periférico NCMS000
T157	AQ 914 922	superior
#157	Norm T157	superior AQ0CS0
T158	SP 923 925	en
#158	Norm T158	en SPS00
T159	NC 926 934	semiluna
#159	Norm T159	semiluna NCFS000
T160	SP 935 938	con
#160	Norm T160	con SPS00
T161	NC 939 953	adelgazamiento
#161	Norm T161	adelgazamiento NCMS000
T162	AQ 954 962	estromal
#162	Norm T162	estromal AQ0CS0
T163	NC 963 970	extremo
#163	Norm T163	extremo NCMS000
T164	VM 971 979	asociado
#164	Norm T164	asociar VMP00SM
T165	SP 980 981	a
#165	Norm T165	a SPS00
T166	NC 982 992	escleritis
#166	Norm T166	escleritis NCFN000
T167	Fp 992 993	.
#167	Norm T167	. Fp
T168	DA 994 996	El
#168	Norm T168	el DA0MS0
T169	NC 997 1004	cultivo
#169	Norm T169	cultivo NCMS000
T170	SP 1005 1008	del
#170	Norm T170	de+el SPS00+DA0MS0
T171	NC 1009 1016	raspado
#171	Norm T171	raspado NCMS000
T172	AQ 1017 1024	corneal
#172	Norm T172	corneal AQ0CS0
T173	AQ 1025 1033	negativo
#173	Norm T173	negativo AQ0MS0
T174	Fp 1033 1034	.
#174	Norm T174	. Fp
T175	SP 1035 1039	Ante
#175	Norm T175	ante SPS00
T176	DA 1040 1042	la
#176	Norm T176	el DA0FS0
T177	NC 1043 1051	sospecha
#177	Norm T177	sospecha NCFS000
T178	SP 1052 1054	de
#178	Norm T178	de SPS00
T179	NC 1055 1058	QUP
#179	Norm T179	QUP NC00000
T180	AQ 1059 1064	grave
#180	Norm T180	grave AQ0CS0
T181	P0 1065 1067	se
#181	Norm T181	se P00CN000
T182	VM 1068 1074	inicia
#182	Norm T182	iniciar VMIP3S0
T183	NC 1075 1086	tratamiento
#183	Norm T183	tratamiento NCMS000
T184	SP 1087 1090	con
#184	Norm T184	con SPS00
T185	NC 1091 1101	prednisona
#185	Norm T185	prednisona NCFS000
T186	Z 1102 1103	1
#186	Norm T186	1 Z
T187	NC 1103 1105	mg
#187	Norm T187	mg NC00000
T188	Fh 1105 1106	/
#188	Norm T188	/ Fh
T189	NC 1106 1108	kg
#189	Norm T189	kg NC00000
T190	Fh 1108 1109	/
#190	Norm T190	/ Fh
T191	NC 1109 1112	día
#191	Norm T191	día NCMS000
T192	NC 1113 1116	vía
#192	Norm T192	vía NCFS000
T193	AQ 1117 1121	oral
#193	Norm T193	oral AQ0CS0
T194	SP 1122 1125	sin
#194	Norm T194	sin SPS00
T195	NC 1126 1135	respuesta
#195	Norm T195	respuesta NCFS000
T196	Fp 1135 1136	.
#196	Norm T196	. Fp
T197	P0 1137 1139	Se
#197	Norm T197	se P00CN000
T198	VM 1140 1145	pauta
#198	Norm T198	pautar VMIP3S0
T199	NC 1146 1155	megadosis
#199	Norm T199	megadosis NCFN000
T200	SP 1156 1158	de
#200	Norm T200	de SPS00
T201	NC 1159 1176	metilprednisolona
#201	Norm T201	metilprednisolona NCFS000
T202	Z 1177 1178	1
#202	Norm T202	1 Z
T203	NC 1178 1179	g
#203	Norm T203	g NC00000
T204	Fh 1179 1180	/
#204	Norm T204	/ Fh
T205	Z 1180 1182	IV
#205	Norm T205	IV Z
T206	Fh 1182 1183	/
#206	Norm T206	/ Fh
T207	Z 1183 1184	3
#207	Norm T207	3 Z
T208	NC 1185 1189	días
#208	Norm T208	día NCMP000
T209	Fp 1189 1190	.
#209	Norm T209	. Fp
T210	RG 1191 1197	Además
#210	Norm T210	además RG
T211	Fc 1197 1198	,
#211	Norm T211	, Fc
T212	P0 1199 1201	se
#212	Norm T212	se P00CN000
T213	PP 1202 1204	le
#213	Norm T213	le PP3CSD00
T214	VM 1205 1212	realiza
#214	Norm T214	realizar VMIP3S0
T215	DI 1213 1216	una
#215	Norm T215	uno DI0FS0
T216	NC 1217 1226	resección
#216	Norm T216	resección NCFS000
T217	AQ 1227 1237	quirúrgica
#217	Norm T217	quirúrgico AQ0FS0
T218	SP 1238 1241	del
#218	Norm T218	de+el SPS00+DA0MS0
T219	NC 1242 1248	tejido
#219	Norm T219	tejido NCMS000
T220	AQ 1249 1260	conjuntival
#220	Norm T220	conjuntival AQ0CS0
T221	AQ 1261 1270	adyacente
#221	Norm T221	adyacente AQ0CS0
T222	SP 1271 1272	a
#222	Norm T222	a SPS00
T223	DA 1273 1275	la
#223	Norm T223	el DA0FS0
T224	NC 1276 1279	QUP
#224	Norm T224	QUP NC00000
T225	CC 1280 1281	y
#225	Norm T225	y CC
T226	NC 1282 1290	adhesivo
#226	Norm T226	adhesivo NCMS000
T227	SP 1291 1293	de
#227	Norm T227	de SPS00
T228	NC 1294 1307	cianoacrilato
#228	Norm T228	cianoacrilato NCMS000
T229	SP 1308 1312	para
#229	Norm T229	para SPS00
T230	VM 1313 1319	evitar
#230	Norm T230	evitar VMN0000
T231	DA 1320 1322	la
#231	Norm T231	el DA0FS0
T232	NC 1323 1334	perforación
#232	Norm T232	perforación NCFS000
T233	AQ 1335 1341	ocular
#233	Norm T233	ocular AQ0CS0
T234	Fp 1341 1342	.
#234	Norm T234	. Fp
T235	DA 1343 1345	La
#235	Norm T235	el DA0FS0
T236	NC 1346 1354	paciente
#236	Norm T236	paciente NCCS000
T237	VM 1355 1363	responde
#237	Norm T237	responder VMIP3S0
T238	RG 1364 1374	pobremente
#238	Norm T238	pobremente RG
T239	SP 1375 1377	al
#239	Norm T239	a+el SPS00+DA0MS0
T240	NC 1378 1389	tratamiento
#240	Norm T240	tratamiento NCMS000
T241	Fc 1389 1390	,
#241	Norm T241	, Fc
T242	SP 1391 1394	con
#242	Norm T242	con SPS00
T243	NC 1395 1407	persistencia
#243	Norm T243	persistencia NCFS000
T244	SP 1408 1411	del
#244	Norm T244	de+el SPS00+DA0MS0
T245	NC 1412 1417	dolor
#245	Norm T245	dolor NCMS000
T246	Fc 1417 1418	,
#246	Norm T246	, Fc
T247	DA 1419 1421	la
#247	Norm T247	el DA0FS0
T248	NC 1422 1432	escleritis
#248	Norm T248	escleritis NCFN000
T249	CC 1433 1434	y
#249	Norm T249	y CC
T250	DA 1435 1437	el
#250	Norm T250	el DA0MS0
T251	VM 1438 1448	infiltrado
#251	Norm T251	infiltrar VMP00SM
T252	AQ 1449 1456	corneal
#252	Norm T252	corneal AQ0CS0
T253	Fp 1456 1457	.
#253	Norm T253	. Fp
T254	CS 1458 1462	Como
#254	Norm T254	como CS
T255	RG 1463 1469	además
#255	Norm T255	además RG
T256	RN 1470 1472	no
#256	Norm T256	no RN
T257	VM 1473 1480	existía
#257	Norm T257	existir VMII3S0
T258	DI 1481 1483	un
#258	Norm T258	uno DI0MS0
T259	AQ 1484 1490	óptimo
#259	Norm T259	bueno AQSMS0
T260	NC 1491 1498	control
#260	Norm T260	control NCMS000
T261	SP 1499 1501	de
#261	Norm T261	de SPS00
T262	DP 1502 1504	su
#262	Norm T262	su DP3CS0
T263	NC 1505 1515	enfermedad
#263	Norm T263	enfermedad NCFS000
T264	SP 1516 1518	de
#264	Norm T264	de SPS00
T265	NC 1519 1523	base
#265	Norm T265	base NCCS000
T266	Fc 1523 1524	,
#266	Norm T266	, Fc
T267	VM 1525 1534	decidimos
#267	Norm T267	decidir VMIS1P0
T268	VM 1535 1542	iniciar
#268	Norm T268	iniciar VMN0000
T269	NC 1543 1552	perfusión
#269	Norm T269	perfusión NCFS000
T270	SP 1553 1555	de
#270	Norm T270	de SPS00
T271	NC 1556 1565	rituximab
#271	Norm T271	rituximab NCMS000
T272	Z 1566 1567	1
#272	Norm T272	1 Z
T273	NC 1567 1568	g
#273	Norm T273	g NC00000
T274	Fh 1568 1569	/
#274	Norm T274	/ Fh
T275	NC 1569 1573	i.v.
#275	Norm T275	i.v. NCFS000
T276	Z 1574 1577	dos
#276	Norm T276	2 Z
T277	NC 1578 1588	infusiones
#277	Norm T277	infusión NCFP000
T278	VM 1589 1598	separadas
#278	Norm T278	separar VMP00PF
T279	Z 1599 1601	15
#279	Norm T279	15 Z
T280	NC 1602 1606	días
#280	Norm T280	día NCMP000
T281	Fp 1606 1607	.
#281	Norm T281	. Fp
T282	SP 1608 1609	A
#282	Norm T282	A SPS00
T283	DA 1610 1613	las
#283	Norm T283	el DA0FP0
T284	Z 1614 1615	3
#284	Norm T284	3 Z
T285	NC 1616 1623	semanas
#285	Norm T285	semana NCFP000
T286	SP 1624 1627	del
#286	Norm T286	de+el SPS00+DA0MS0
T287	NC 1628 1634	inicio
#287	Norm T287	inicio NCMS000
T288	SP 1635 1638	del
#288	Norm T288	de+el SPS00+DA0MS0
T289	NC 1639 1650	tratamiento
#289	Norm T289	tratamiento NCMS000
T290	P0 1651 1653	se
#290	Norm T290	se P00CN000
T291	VM 1654 1661	aprecia
#291	Norm T291	apreciar VMIP3S0
T292	NC 1662 1669	mejoría
#292	Norm T292	mejoría NCFS000
T293	AQ 1670 1677	clínica
#293	Norm T293	clínico AQ0FS0
T294	AQ 1678 1691	significativa
#294	Norm T294	significativo AQ0FS0
T295	Fc 1691 1692	,
#295	Norm T295	, Fc
T296	VM 1693 1704	presentando
#296	Norm T296	presentar VMG0000
T297	NC 1705 1712	leucoma
#297	Norm T297	leucoma NCMS000
T298	AQ 1713 1720	corneal
#298	Norm T298	corneal AQ0CS0
T299	SP 1721 1723	de
#299	Norm T299	de SPS00
T300	NC 1724 1731	aspecto
#300	Norm T300	aspecto NCMS000
T301	AQ 1732 1740	inactivo
#301	Norm T301	inactivo AQ0MS0
T302	SP 1741 1744	sin
#302	Norm T302	sin SPS00
T303	NC 1745 1755	escleritis
#303	Norm T303	escleritis NCFN000
T304	Fp 1755 1756	.
#304	Norm T304	. Fp
T305	RG 1757 1768	Actualmente
#305	Norm T305	actualmente RG
T306	VM 1769 1777	mantiene
#306	Norm T306	mantener VMIP3S0
T307	NC 1778 1789	tratamiento
#307	Norm T307	tratamiento NCMS000
T308	SP 1790 1793	con
#308	Norm T308	con SPS00
T309	NC 1794 1803	rituximab
#309	Norm T309	rituximab NCMS000
T310	NC 1804 1808	i.v.
#310	Norm T310	i.v. NCFS000
T311	SP 1809 1811	en
#311	Norm T311	en SPS00
T312	NC 1812 1817	pauta
#312	Norm T312	pauta NCFS000
T313	SP 1818 1820	de
#313	Norm T313	de SPS00
T314	NC 1821 1823	AR
#314	Norm T314	AR NC00000
T315	DI 1824 1828	cada
#315	Norm T315	cada DI0CS0
T316	Z 1829 1830	8
#316	Norm T316	8 Z
T317	NC 1831 1836	meses
#317	Norm T317	mes NCMP000
T318	SP 1837 1840	con
#318	Norm T318	con SPS00
T319	AQ 1841 1845	buen
#319	Norm T319	bueno AQ0MS0
T320	NC 1846 1853	control
#320	Norm T320	control NCMS000
T321	AQ 1854 1861	clínico
#321	Norm T321	clínico AQ0MS0
T322	Fp 1861 1862	.
#322	Norm T322	. Fp
